Bioxcel Therapeutics BTAI 深 滬
交易中 09-20 15:20:47 美东时间
0.594
-0.062
-9.48%
華盛通- 最 高0.67
- 今 開0.6665
- 成交量 45.34万股
- 最 低 0.5922
- 昨 收 0.6562
- 總市值 1804.68万
- 52周最高 5.6199
- 市盈率 靜 --
- 換手率 1.49%
- 52周最低 0.53
- 委 比 95.44%
- 總股本 3038.19万
- 歷史最高 71.50
- 量 比 0.42
- 振 幅 11.86%
- 歷史最低 0.53
- 每 手 1
- 風險率 1.09%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bioxcel Therapeutics Announces Restructuring and Leadership Changes
Bioxcel Therapeutics ( ($BTAI) ) has provided an announcement. BioXcel Therapeu...
09-19 19:28
新浪财经ESG：BTAI 路孚特（Refinitiv）ESG评级调降至D
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
09-02 07:01
Bioxcel Therapeutics (BTAI) Receives a Hold from Mizuho Securities
In a report released on August 9, Graig Suvannavejh from Mizuho Securities main...
08-12 14:27
快讯 | Bioxcel Therapeutics第二季度净利润美元指数-8,299,000，而IBES估计为美元指数-25,800,000。
BioXcel Therapeutics Q2 Net Income USD -8.299 Million Vs. IBES Estimate USD -25...
08-06 19:00
Here is the next potential market catalyst
Major earnings expected before the bell on Tuesday include: Caterpillar (CAT) Duke Energy (DUK) Marathon Petroleum (MPC) Organon (OGN) Uber Technologies (UBER) Other earnings slated for release before...
08-06 06:00
Canaccord Genuity Maintains Buy on BioXcel Therapeutics, Maintains $7 Price Target
Canaccord Genuity analyst Sumant Kulkarni maintains BioXcel Therapeutics (NASDAQ:BTAI) with a Buy and maintains $7 price target.
06-27 21:32
BioXcel Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.
BioXcel Therapeutics shares are trading higher after the company reported bette...
05-10 00:36
Notable earnings before Thursday's open
Major earnings expected before the bell on Thursday include: Medical Properties Trust (MPW) Plug Power (PLUG) Roblox (RBLX) Viatris (VTRS) Warner Bros. Discovery (WBD) Other earnings slated for releas...
05-09 00:34
Bioxcel Therapeutics Advances SERENITY Trial and Strategy
Bioxcel Therapeutics Inc (BTAI) just unveiled an update. BioXcel Therapeutics, ...
04-22 19:22
Bioxcel Therapeutics Advances Alzheimer’s Agitation Treatment Trial
Bioxcel Therapeutics Inc (BTAI) has shared an update. BioXcel Therapeutics has ...
04-10 19:22
